Chronic Dry Eye Disease

M&S Technologies and Bruder Healthcare have announced the launch of the M&S Bruder Ocular Surface Analyzer, an all-in-one device that captures and provides test results for dry eye disease in as little as 15 seconds per eye.

Lumenis announced the launch of OptiPlus, its new dual-frequency radiofrequency device that delivers heat across different tissue layers to increase blood circulation and target dry eye inflammation due to meibomian gland dysfunction.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Brandon D. Ayres, MD, discusses data from the SAHARA trial, which evaluated patients with dry eye disease and meibomian gland dysfunction.

Aldeyra Therapeutics has entered into an exclusive option agreement with AbbVie for license to develop, manufacture and commercialize reproxalap, the company announced in a press release.

Hands-on workshops and high-level education engaged attendees at this year’s Twin Cities Ocular Surface Disease Symposium, which offered a host of events related to research, diagnosis and management of ocular surface disease.

NEW YORK — In this Healio Video Perspective from OSN New York, Jennifer Loh, MD, discusses why ophthalmologists must be aware of the crossover between thyroid eye disease and dry eye disease.

Well now, it seems as though I ruffled more than a few feathers with my annual anti-inflammatory review last month.

NEW ORLEANS — Research presented at Academy ’23 demonstrated that perfluorohexyloctane, which is indicated for dry eye disease, reduces corneal staining up to four times more than saline.

Over the last 18 months, rapid developments have occurred in the dry eye and ocular surface disease space.